Category stocks

Agios Pharmaceuticals Posts Q2 Loss

Agios Pharmaceuticals reports Q2 GAAP EPS of -$1.69 Agios Pharmaceuticals reported a Q2 GAAP EPS of -$1.69, missing by $0.02. The company's revenue was $44.75M, beating by $18.05M with a 259.1% year-over-year increase. As of June 30, 2026, Agios had $964.8 millio